COYA Butterfly Strategy
COYA (Coya Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. It is also developing COYA 201, an allogeneic Treg exosome product candidate that is in preclinical stage for use in the treatment of neurodegenerative, autoimmune, and metabolic diseases; and COYA 206, an antigen directed Treg-derived exosome product candidate, which is in discovery stage. The company was incorporated in 2020 and is headquartered in Houston, Texas.
COYA (Coya Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $75.9M, a beta of 0.55 versus the broader market, a 52-week range of 3.71-7.75, average daily share volume of 143K, a public-listing history dating back to 2022, approximately 8 full-time employees. These structural characteristics shape how COYA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.55 indicates COYA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a butterfly on COYA?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current COYA snapshot
As of May 15, 2026, spot at $5.02, ATM IV 98.30%, IV rank 19.78%, expected move 28.18%. The butterfly on COYA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this butterfly structure on COYA specifically: COYA IV at 98.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a COYA butterfly, with a market-implied 1-standard-deviation move of approximately 28.18% (roughly $1.41 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated COYA expiries trade a higher absolute premium for lower per-day decay. Position sizing on COYA should anchor to the underlying notional of $5.02 per share and to the trader's directional view on COYA stock.
COYA butterfly setup
The COYA butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With COYA near $5.02, the first option leg uses a $4.77 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed COYA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 COYA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $4.77 | N/A |
| Sell 2 | Call | $5.02 | N/A |
| Buy 1 | Call | $5.27 | N/A |
COYA butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
COYA butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on COYA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on COYA
Butterflies on COYA are pinning bets - traders use them when they expect COYA to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
COYA thesis for this butterfly
The market-implied 1-standard-deviation range for COYA extends from approximately $3.61 on the downside to $6.43 on the upside. A COYA long call butterfly is a pinning play: it pays maximum at the middle strike if COYA settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current COYA IV rank near 19.78% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on COYA at 98.30%. As a Healthcare name, COYA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to COYA-specific events.
COYA butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. COYA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move COYA alongside the broader basket even when COYA-specific fundamentals are unchanged. Always rebuild the position from current COYA chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on COYA?
- A butterfly on COYA is the butterfly strategy applied to COYA (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With COYA stock trading near $5.02, the strikes shown on this page are snapped to the nearest listed COYA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are COYA butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the COYA butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 98.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a COYA butterfly?
- The breakeven for the COYA butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current COYA market-implied 1-standard-deviation expected move is approximately 28.18%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on COYA?
- Butterflies on COYA are pinning bets - traders use them when they expect COYA to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current COYA implied volatility affect this butterfly?
- COYA ATM IV is at 98.30% with IV rank near 19.78%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.